These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort. Quijano-Roy S; Haberlova J; Castiglioni C; Vissing J; Munell F; Rivier F; Stojkovic T; Malfatti E; Gómez García de la Banda M; Tasca G; Costa Comellas L; Benezit A; Amthor H; Dabaj I; Gontijo Camelo C; Laforêt P; Rendu J; Romero NB; Cavassa E; Fattori F; Beroud C; Zídková J; Leboucq N; Løkken N; Sanchez-Montañez Á; Ortega X; Kynčl M; Metay C; Gómez-Andrés D; Carlier RY J Neurol; 2022 May; 269(5):2414-2429. PubMed ID: 34559299 [TBL] [Abstract][Full Text] [Related]
5. LAMA2-related myopathy: Frequency among congenital and limb-girdle muscular dystrophies. Løkken N; Born AP; Duno M; Vissing J Muscle Nerve; 2015 Oct; 52(4):547-53. PubMed ID: 25663498 [TBL] [Abstract][Full Text] [Related]
6. Brain MRI Abnormalities, Epilepsy and Intellectual Disability in LAMA2 Related Dystrophy - a Genotype/Phenotype Correlation. Camelo CG; Artilheiro MC; Martins Moreno CA; Ferraciolli SF; Serafim Silva AM; Fernandes TR; Lucato LT; Rocha AJ; Reed UC; Zanoteli E J Neuromuscul Dis; 2023; 10(4):483-492. PubMed ID: 37182895 [TBL] [Abstract][Full Text] [Related]
7. Natural history, outcome measures and trial readiness in LAMA2-related muscular dystrophy and SELENON-related myopathy in children and adults: protocol of the LAST STRONG study. Bouman K; Groothuis JT; Doorduin J; van Alfen N; Udink Ten Cate FEA; van den Heuvel FMA; Nijveldt R; van Tilburg WCM; Buckens SCFM; Dittrich ATM; Draaisma JMT; Janssen MCH; Kamsteeg EJ; van Kleef ESB; Koene S; Smeitink JAM; Küsters B; van Tienen FHJ; Smeets HJM; van Engelen BGM; Erasmus CE; Voermans NC BMC Neurol; 2021 Aug; 21(1):313. PubMed ID: 34384384 [TBL] [Abstract][Full Text] [Related]
8. A Homozygous LAMA2 Mutation of c.818G>A Caused Partial Merosin Deficiency in a Japanese Patient. Kubota A; Ishiura H; Mitsui J; Sakuishi K; Iwata A; Yamamoto T; Nishino I; Tsuji S; Shimizu J Intern Med; 2018 Mar; 57(6):877-882. PubMed ID: 29225264 [TBL] [Abstract][Full Text] [Related]
9. Natural history and genetic study of LAMA2-related muscular dystrophy in a large Chinese cohort. Tan D; Ge L; Fan Y; Chang X; Wang S; Wei C; Ding J; Liu A; Wang S; Li X; Gao K; Yang H; Que C; Huang Z; Li C; Zhu Y; Mao B; Jin B; Hua Y; Zhang X; Zhang B; Zhu W; Zhang C; Wang Y; Yuan Y; Jiang Y; Rutkowski A; Bönnemann CG; Wu X; Xiong H Orphanet J Rare Dis; 2021 Jul; 16(1):319. PubMed ID: 34281576 [TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular genetic analysis of a family with late-onset LAMA2-related muscular dystrophy. Ding J; Zhao D; Du R; Zhang Y; Yang H; Liu J; Yan C; Zhang F; Xiong H Brain Dev; 2016 Feb; 38(2):242-9. PubMed ID: 26304763 [TBL] [Abstract][Full Text] [Related]
11. LAMA2-related congenital muscular dystrophy complicated by West syndrome. Camacho A; Núñez N; Dekomien G; Hernández-Laín A; de Aragón AM; Simón R Eur J Paediatr Neurol; 2015 Mar; 19(2):243-7. PubMed ID: 25500573 [TBL] [Abstract][Full Text] [Related]
12. Clinical and genomic characteristics of LAMA2 related congenital muscular dystrophy in a patients' cohort from Qatar. A population specific founder variant. Abdel Aleem A; Elsaid MF; Chalhoub N; Chakroun A; Mohamed KAS; AlShami R; Kuzu O; Mohamed RB; Ibrahim K; AlMudheki N; Osman O; Ross ME; ELalamy O Neuromuscul Disord; 2020 Jun; 30(6):457-471. PubMed ID: 32444167 [TBL] [Abstract][Full Text] [Related]